Related Experiment Video
Updated: Jul 4, 2026

11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
Management of a patient with stage IIIA (N2) NSCLC
Kathryn Carlson1, B Zach Fowler, Daniel L Miller
1Department of Hematology and Medical Oncology, Emory University, School of Medicine, Emory Winship Cancer Institute, Atlanta, Georgia 30322, USA.
Oncology (Williston Park, N.Y.)
|June 7, 2008
Abstract:
The appropriate treatment of patients with stage IIIA (N2) nonsmall-cell lung cancer (NSCLC) is unclear. With this case report and review, we address the history, assessment, and management of a 67-year-old patient with this diagnosis, and then discuss the challenges in managing N2 disease, as well as the roles of systemic therapy, surgery, and postoperative radiation therapy.